Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Aflibercept in myopic choroidal neovascularization: Added benefit not proven

EurekAlert! - 1 Mar 2016 07:00
(Institute for Quality and Efficiency in Health Care) The drug manufacturer presented no relevant study data for the new therapeutic indication and also claimed no added benefit.
Full Article at EurekAlert!

More Medical News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard